Skip to content

Karolinska Cardiorenal Theme-centre and StockholmHeartbank

Stockholmheartbank and Karolinska Cardiorenal Theme-centre, From Genome to Clinical Practice in Patients With Acute Coronary Syndrome and Impaired Kidney Function

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01204645
Acronym
KKT
Enrollment
10000
Registered
2010-09-17
Start date
2010-05-31
Completion date
2024-01-31
Last updated
2017-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndrome, Chronic Kidney Disease, Chronic Renal Failure, Ischemic Heart Disease, Myocardial Infarction

Brief summary

Chronic kidney disease (CKD) affects 10-18% of the adult population and is becoming recognized as one of the most serious disorders causing increased risk for cardiovascular disease and death. In patients with ischemic heart disease 26% have increased creatinine, which rises to 40% if patients also have diabetes mellitus. Risk increases as renal function diminishes, and just slowing the rate of decline in renal function would have a tremendous impact on health and morbidity. This association is commonly termed the Cardiorenal Syndrome, though it is caused by a much more complex interplay between major pathogenetic pathways such as glucose metabolism and diabetes, systemic and tissue inflammation, tissue metabolism, coagulation, mineral metabolism, sympathetic activation, renin-angiotensin-aldosterone system activation, endothelial dysfunction, lipid metabolism, fetal programming etc. Karolinska Institutet recently merged basic and clinical researchers in all these fields, creating a Karolinska Kardiorenal Theme Centre; ultimately aiming to explore the syndrome and provide improved care for the individual patient. The investigators road to success: * Creating a Biobank (blood, DNA, plasma) from the majority of all hosptalized patients with ACS in Stockholm county - Stockholmheartbank. * This Theme Center include all teaching hospitals associated with Karolinska Institutet; Danderyd University Hospital, Karolinska University Hospital and Södersjukhuset University Hospital. Together theses hospitals serve as emergency hospitals for 1.9 million people. The investigators are aiming at creating a biobank from all patients admitted for an acute coronary event (about 2.300/yr), which is a unique asset for molecular and genetic research as well as observational and intervention studies. * The investigators have access to the National registry with 100% coverage, that contains data on all patients admitted to Stockholms coronary care units since 1995. * To ensure translation in to clinical practice, most of the researchers are also MD:s, and several are clinically active. * The clinical network facilitates the development of novel therapies and translational research. * Steering groups for Education and a Clinical Practice implementation program.

Interventions

None listed

Sponsors

Region Stockholm
CollaboratorOTHER_GOV
Karolinska Institutet
CollaboratorOTHER
Uppsala University
CollaboratorOTHER
Lund University
CollaboratorOTHER
Stockholm South General Hospital
CollaboratorOTHER
Karolinska University Hospital
CollaboratorOTHER
Danderyd Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* All patients admitted to one of the four major emergency hospitals in Stockholm, for an acute coronary event. * All patients admitted to one of the four major emergency hospitals in Stockholm, for an elective coronary angiography

Exclusion criteria

* Severe hemodynamic instability with the need of inotropic therapy and at the same time anemia with haemoglobin \<1.1 g/dL

Design outcomes

Primary

MeasureTime frameDescription
Composite1 yearCombined endpoint of death, new cardiovascular event or dialysis.

Secondary

MeasureTime frameDescription
Renal function decline5 year
Vascular function1 yearVascular function assessed by arterial stiffness, microcirculation by Laser-Doppler

Countries

Sweden

Contacts

Primary ContactJonas Spaak, MD, PhD
jonas.spaak@ki.se+46 762014178

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026